icon
icon
icon
icon
Upgrade
icon

Hourly Market Review - Oct 16, 2024 13 PM

AInvestWednesday, Oct 16, 2024 1:00 pm ET
1min read

Movers of the hour:


Korro Bio is up 117.01% at $87.58.

ProQR Therapeutics is up 75.69% at $3.18.

Wave Life Sciences is up 75.18% at $15.00.

Oklo is up 39.57% at $16.25.

NuScale Power is up 33.36% at $18.18.

Here are the top stocks upgraded by Wall Street analyst:

Apple has received a rating of Neutral from Piper Sandler with target price increased to $225 from $225.

Apple has received a rating of Neutral from Jefferies with target price increased to $213 from $205.

Apple has received a rating of Strong Buy from B of A Securities with target price increased to $256 from $256.

Apple has received a rating of Sell from Barclays with target price increased to $186 from $186.

Apple has received a rating of Neutral from New Street Research with target price increased to $225 from $225.

Apple has received a rating of Strong Buy from Needham with target price increased to $260 from $260.

Apple has received a rating of Strong Buy from Needham with target price increased to $260 from $260.

Apple has received a rating of Buy from Evercore ISI Group with target price increased to $250 from $250.

Nvidia has received a rating of Strong Buy from Goldman Sachs with target price increased to $150 from $135.

Nvidia has received a rating of Buy from Morgan Stanley with target price increased to $150 from $150.

Disclaimer: the above is a summary showing certain market information. AInvest is not responsible for any data errors, omissions or other information that may be displayed incorrectly as the data is derived from a third party source. Communications displaying market prices, data and other information available in this post are meant for informational purposes only and are not intended as an offer or solicitation for the purchase or sale of any security. Please do your own research when investing. All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit, or protect against loss in a down market.